Implementing rotavirus vaccination in Asia

Vaccine

Volumn 25, Issue 44, 2007, Pages 7711-7716

  Santosham, Mathuram ^a   Nelson, E Anthony S ^b   Bresee, Joseph S ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

Asia; Rotavirus vaccine; Vaccine implementation

Indexed keywords

ORAL REHYDRATION SOLUTION; ROTAVIRUS VACCINE;

ABSENCE OF SIDE EFFECTS; ARTICLE; ASIA; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; TREATMENT PLANNING; VACCINATION;

ASIA; COST OF ILLNESS; HUMANS; IMMUNIZATION PROGRAMS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINATION;

EID: 35048886502     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.07.064     Document Type: Article

References (38)

1. Bryce J., Boschi-Pinto C., Shibuya K., Black R.E., and WHO Child Health Epidemiology Reference Group. WHO estimates of the causes of death in children. Lancet 365 9465 (2005) 1147-1152
2. Glass R.I., Bresee J.S., Turcios R., Fischer T.K., Parashar U.D., and Steele A.D. Rotavirus vaccines: targeting the developing world. J Infect Dis 192 Suppl. 1 (2005) S160-S166
3. Parashar U.D., Hummelman E.G., Bresee J.S., Miller M.A., and Glass R.I. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 9 5 (2003) 565-572
4. Parashar U.D., Gibson C.J., Bresee J.S., and Glass R.I. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 12 2 (2006) 304-306
5. Bresee J.S., Hummelman E., Nelson E.A.S., and Glass R.I. Rotavirus in Asia: the value of surveillance for informing decisions about the introduction of new vaccines. J Infect Dis 192 Suppl. 1 (2005) S1-S5
6. Fischer T.K., Bresee J.S., and Glass R.I. Rotavirus vaccines and the prevention of hospital-acquired diarrhea in children. Vaccine 22 Suppl. 1 (2004) S49-S54
7. Fang Z.Y., Wang B., Kilgore P.E., Bresee J.S., Zhang Y.L., Sun L.W., et al. Sentinel hospital surveillance for rotavirus diarrhea in the People's Republic of China, August 2001-July 2003. J Infect Dis 192 Suppl. 1 (2005) S94-S99
8. Bahl R., Ray P., Subodh S., Shambharkar P., Saxena M., Parashar U., et al. Incidence of severe rotavirus diarrhea in New Delhi, India, and G and P types of the infecting rotavirus strains. J Infect Dis 192 Suppl. 1 (2005) S114-S119
9. Kim J.S., Kang J.O., Cho S.C., Jang Y.T., Min S.A., Park T.H., et al. Epidemiological profile of rotavirus infection in the Republic of Korea: results from prospective surveillance in the Jeongeub district, 1 July 2002 through 30 June 2004. J Infect Dis 192 Suppl. 1 (2005) S49-S56
10. Chen K.T., Chen P.Y., Tang R.B., Huang Y.F., Lee P.I., Yang J.Y., et al. Sentinel hospital surveillance for rotavirus diarrhea in Taiwan, 2001-2003. J Infect Dis 192 Suppl. 1 (2005) S44-S48
11. Jiraphongsa C., Bresee J.S., Pongsuwanna Y., Kluabwang P., Poonawagul U., Arporntip P., et al. Epidemiology and burden of rotavirus diarrhea in Thailand: results of sentinel surveillance. J Infect Dis 192 Suppl. 1 (2005) S87-S93
12. Van Man N., Luan le T., Trach D.D., Thanh N.T., Van Tu P., Long N.T., et al. Epidemiological profile and burden of rotavirus diarrhea in Vietnam: 5 years of sentinel hospital surveillance, 1998-2003. J Infect Dis 192 Suppl. 1 (2005) S127-S132
13. World Health Organization. Rotavirus Vaccines: WHO Position Paper. Wkly Epidemiol Rec 1999;74(5):33-40. Available at www.who.int/docstore/wer/pdf/1999/wer7405.pdf (accessed October 2006).
14. Nelson E.A.S., Tam J.S., Yu L.-M., Ng Y.-C., Bresee J.S., Poon K.-H., et al. Hospital-based study of the economic burden associated with rotavirus diarrhea in Hong Kong. J Infect Dis 192 Suppl. 1 (2005) S64-S70
15. Fischer T.K., Anh D.D., Antil L., Cat N.D., Kilgore P.E., Thiem V.D., et al. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam. J Infect Dis 192 10 (2005) 1720-1726
16. World Health Organization. Report of the meeting on future directions for rotavirus vaccine research in developing countries. Geneva, Switzerland, 9-11 February 2000. Available at www.who.int/vaccines-documents/DocsPDF00/www531.pdf (accessed October 2006).
17. Podewils L.J., Antil L., Hummelman E., Bresee J., Parashar U.D., and Rheingans R. Projected cost-effectiveness of rotavirus vaccination for children in Asia. J Infect Dis 192 Suppl. 1 (2005) S133-S145
18. Zissis G., Lambert J.P., Marbehant P., Marissens D., Lobmann M., Charlier P., et al. Protection studies in colostrum-deprived piglets of a bovine rotavirus vaccine candidate using human rotavirus strains for challenge. J Infect Dis 148 6 (1983) 1061-1068
19. Vesikari T., Isolauri E., Delem A., D'Hondt E., Andre F.E., and Zissis G. Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children. Lancet 2 8354 (1983) 807-811
20. Murphy T.V., Gargiullo P.M., Massoudi M.S., Nelson D.B., Jumaan A.O., Okoro C.A., et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 344 8 (2001) 564-572
21. Centers for Disease Control and Prevention. Withdrawal of Rotavirus Vaccine Recommendation. Morb Mortal Wkly Rep 1999; 48(43):1007. Available at www.cdc.gov/mmwr/preview/mmwrhtml/mm4843a5.htm (accessed October 2006).
22. De Mol P., Zissis G., Butlzler J.P., Mutwewingabo A., and Andre F.E. Failure of live, attenuated oral rotavirus vaccine. Lancet 2 8498 (1986) 108
23. Hanlon P., Hanlon L., Marsh V., Byass P., Shenton F., Hassan-King M., et al. Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants. Lancet 1 8546 (1987) 1342-1345
24. Lanata C.F., Black R.E., del Aguila R., Gil A., Verastegui H., Gerna G., et al. Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine. J Infect Dis 159 3 (1989) 452-459
25. Georges-Courbot M.C., Monges J., Siopathis M.R., Roungou J.B., Gresenguet G., Bellec L., et al. Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa. Res Virol 142 5 (1991) 405-411
26. United Nations Children's Fund. State of the world's children, 1996. Available at www.unicef.org/sowc96/1990s.htm (accessed December 2006).
27. Bresee J.S., Glass R.I., Ivanoff B., and Gentsch J.R. Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries. Vaccine 17 18 (1999) 2207-2222
28. Ruiz-Palacios G.M., Perez-Schael I., Velazquez F.R., Abate H., Breuer T., Clemens S.C., et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. New Eng J Med 354 1 (2006) 11-22
29. Vesikari T., Matson D.O., Dennehy P., Van Damme P., Santosham M., Rodriguez Z., et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354 (2006) 23-33
30. De Vos B., Vesikari T., Linhares A.C., Salinas B., Perez-Schael I., Ruiz-Palacios G.M., et al. A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis. Pediatr Infect Dis J 23 Suppl. 10 (2004) S179-S182
31. Phua K.B., Quak S.H., Lee B.W., Emmanuel S.C., Goh P., Han H.H., et al. Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants. J Infect Dis 192 Suppl. 1 (2005) S6-S16
32. Clark H.F., Bernstein D.I., Dennehy P.H., Offit P., Pichichero M., Treanor J., et al. Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants. J Pediatr 144 2 (2004) 184-190
33. Glass R.I., Parashar U.D., Bresee J.S., Turcios R., Fischer T.K., Widdowson M.A., et al. Rotavirus vaccines: current prospects and future challenges. Lancet 368 9532 (2006) 323-332
34. Brüssow H., Sidoti J., Lerner L., Rahim H., Eckstein W., Werchau H., et al. Antibodies to seven rotavirus serotypes in cord sera, maternal sera, and colostrum of German women. J Clin Microbiol 29 12 (1991) 2856-2859
35. Rennels M.B. Influence of breast-feeding and oral poliovirus vaccine on the immunogenicity and efficacy of rotavirus vaccines. J Infect Dis 174 Suppl. 1 (1996) S107-S111
36. World Health Organization. Research tools. Available at www.who.int/research/en/ (accessed January 2007).
37. Centers for Disease Control and Prevention. CDC's Advisory Committee Recommends New Vaccine to Prevent Rotavirus. Press release, 21 February 2006. Available at www.cdc.gov/OD/OC/MEDIA/pressrel/r060221.htm (accessed October 2006).
38. Centers for Disease Control and Prevention. Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices. Morb Mortal Wkly Rep 2006;55(RR-12):1-13. Available at www.cdc.gov/mmwr/PDF/rr/rr5512.pdf (accessed October 2006).